How long should we follow patients managed for muscle-invasive bladder cancer? Lesson learned from a recent clinical practice

Abstract

To the Editor, The exact time to stop bladder cancer patient’s follow-up is not well known and there is not a clear recommendation on if and when stop to follow a patient managed for muscle invasive bladder cancer (MIBC). Major urological guidelines do not provide a precise indication on the timing of follow-up, and there is currently no real consensus on optimal time schedule [...].

Keywords

• MIBC
• follow up
• recurrence
• urethra
• ilealconduit